A$1.42 -0.1 -3.7%
Last Trade - 7:10am
| Market Cap | ÂŁ242.7m |
| Enterprise Value | ÂŁ244.7m |
| Revenue | ÂŁ12.7m |
| Position in Universe | th / 1835 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Mar | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.000 | 0.000 | 0.000 | 11.1 | 23.3 | 25.1 | +50.3% | ||||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2020
|
31st Dec 2021
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
Aroa Biosurgery Limited is a New Zealand-based soft tissue repair company. The Company is engaged in commercializing regenerative tissue substitutes for medical conditions where impaired healing leads to serious consequences for patients. It designs and manufactures medical products which enable surgeons and clinicians to repair serious tissue injuries. The Company’s solutions include Endoform platform, Wound Care Portfolio and Reinforced Bioscaffolds. The Endoform platform is a building block for developing a range of regenerative tissue substitutes to assist with tissue repair and healing. Its wound care products comprise extracellular matrix to manage acute and chronic wounds. The Reinforced Bioscaffolds combine the biologics and synthetics to address the surgical ventral hernia repair solutions.
| Last Annual | March 31st, 2020 |
| Last Interim | January 1st, 1970 |
| No. of Shareholders: | n/a |
| No. of Employees: | n/a |
| Sector | Healthcare |
| Industry | Healthcare Equipment & Supplies |
| Index | |
| Exchange | Australian Stock Exchange - SEATS |
| Shares in Issue | 300,074,950 |
| Free Float | (0.0%) |
| Eligible for |
ISAs
SIPPs
|
| Address | 2 Kingsford Smith Place Airport Oaks, AUCKLAND, 2022, New Zealand |
| Web | http://aroabio.com/ |
| Phone | +64 9 8693035 |
| Auditors | BDO Auckland |
As of 7:10am, shares in Aroa Biosurgery are trading at A$1.42, giving the company a market capitalisation of ÂŁ242.7m. This share price information is delayed by 15 minutes.
Shares in Aroa Biosurgery are currently trading at A$1.42 and the price has moved by % over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Aroa Biosurgery price has moved by % over the past year.
Of the analysts with advisory recommendations for Aroa Biosurgery, there are there are currently "buy" , "hold" and "sell" recommendations. The overall consensus recommendation for Aroa Biosurgery is Not available. You can view the full broker recommendation list by unlocking its StockReport.
It is not known when Aroa Biosurgery will next release financial results.
Aroa Biosurgery does not currently pay a dividend.
Aroa Biosurgery does not currently pay a dividend.
Aroa Biosurgery does not currently pay a dividend.
To buy shares in Aroa Biosurgery you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Aroa Biosurgery are currently trading at A$1.42, giving the company a market capitalisation of ÂŁ242.7m.
Here are the trading details for Aroa Biosurgery:
We were not able to load our ranking data for Aroa Biosurgery
We were not able to load any forecast data for Aroa Biosurgery.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Aroa Biosurgery. Over the past six months, the relative strength of its shares against the market has been %. At the current price of A$1.42, shares in Aroa Biosurgery are trading at 2.35% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We were not able to find PE ratio data for Aroa Biosurgery.
We were unable to find the directors for Aroa Biosurgery.
Here are the top five shareholders of Aroa Biosurgery based on the size of their shareholding:
